The functionalities for which we use these technologies may include the following:
Below is a detailed list of the cookies we use, with a description. We classify cookies in the following categories:
Except where allowed by applicable law, we place cookies after having received your consent through the cookie banner or preference center. You can change your cookie settings per cookie category (except for strictly necessary cookies that are required for the proper functioning of the site) at any time by clicking on the “cookie settings” button.
Links to other websites
How to Contact Us
Please see full Prescribing Information, including Patient Information, for PEDMARK.
PEDMARK is a prescription medicine used to decrease the risk of hearing loss in children 1 month of age and older who are receiving cisplatin for solid tumors (cancer) that have not spread to other parts of the body.
It is not known if PEDMARK is safe and effective when given after cisplatin infusions longer than 6 hours.
It is not known if PEDMARK is safe and effective in children less than 1 month of age. PEDMARK is not recommended in children younger than 1 month of age.